ADVANCION EXPANDS U.S. MANUFACTURING CAPABILITIES WITH LAUNCH OF COMMERCIAL MOPS BUFFER PRODUCTION

Investments in strengthening U.S. manufacturing capacity advances Company's commitment to global supply chain security and reliability for critical life science ingredients

BUFFALO GROVE, Ill., Oct. 2, 2025 /PRNewswire/ -- Advancion Corporation ("Advancion" or "Company"), a global leader in life science buffers and proprietary specialty ingredients, today announced the expansion of its U.S.-based manufacturing capabilities with the commercial launch of MOPS buffer produced at its Sterlington, Louisiana facility.

MOPS (3-(N-morpholino)propanesulfonic acid) is a zwitterionic biological buffer commonly used in cell culture and bioprocessing applications to maintain a stable, near-neutral pH. Its low reactivity and minimal interference with biological reactions make it ideal for applications such as protein purification, electrophoresis, cell lysis, and nucleic acid research. MOPS is also widely utilized in diagnostic assays and downstream bioprocessing steps where pH stability is critical to product quality and performance.

"The launch of commercial-scale MOPS production is a key step in strengthening Advancion's leadership in life science buffers," said Liam Doherty, Executive Vice President, Global Life Sciences. "Producing MOPS in-house at our Sterlington facility secures a dependable global supply while maintaining the highest standards of quality, purity, and compliance. This expansion underscores our commitment to transparent, reliable buffer manufacturing and to investing in capacity to fuel growth and innovation across the global biopharmaceutical industry."

MOPS buffer products are produced by Advancion under the Company's single Global Quality Management System, which includes ISO 9001:2015 certified in-process monitoring and facility control systems. Comprehensive quality testing is conducted using validated analytical methods, and may include elemental impurities by ICP-MS, endotoxin, bioburden, DNase, RNase, and protease.

Multi-batch samples of Advancion-manufactured MOPS buffers are available now for customer qualification. For additional information or to order a sample, visit advancionsciences.com/contact, or contact an Advancion Life Sciences representative at [email protected].

ABOUT ADVANCION
Advancion is a leading global producer of specialty ingredients and consumables for biotechnology, pharmaceuticals, home, personal care, and other consumer-oriented and industrial markets. The Company is one of the world's largest producers of life sciences buffers and other proprietary ingredients, providing high-performance products, best-in-class quality and guaranteed supply security for more than 80 years. Through Expression Systems, an Advancion company, the Company produces innovative cell culture media formulations, cell lines, molecular tools and reagents used in the development and commercial manufacturing of advanced therapies. Advancion operates three manufacturing facilities in the U.S. and Germany and serves its global customers through six regional Customer Application Centers located in Chicago, Illinois; Paris, France; São Paulo, Brazil; Singapore; Shanghai, China; and Mumbai, India. The Company is privately owned by Ardian and Golden Gate Capital, and is headquartered in Buffalo Grove, Illinois. For more information, visit advancionsciences.com.

Follow Advancion on LinkedIn.

FOR ADDITIONAL INFORMATION
Advancion Media Relations Scott C. Johnson
+1 847-808-3769
[email protected]

SOURCE Advancion Corporation